RxDoctor Payments Data

David Irwin, MD

Neurology · Philadelphia, PANPI 1194986356

Payments from drug & device makers

What this record shows

That places this record below the midpoint for neurology clinicians in PA, where the typical reported total is $778.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$2,465,195in research payments, 2019–2025

Across 8 payments — averaging $308,149 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2.5M

How this compares

$0 in reported general payments places this provider in the 5th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$24,939
Medicare patients
172
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rivastigmine26$3,340
Quetiapine Fumarate110$3,140
Galantamine Hbr15$2,257
Sertraline Hcl164$1,862
Memantine Hcl79$1,776
Donepezil Hcl128$1,556
Olanzapine12$1,424
Clonazepam69$1,399
Fluvoxamine Maleate14$927
Trazodone Hcl124$801
RivastigmineRivastigmine Tartrate15$466
Escitalopram Oxalate44$465
Risperidone36$452
Mirtazapine21$364
Divalproex Sodium14$279

Paid to pharmacies, not to this prescriber.

Other neurology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →